No Record Found
Sector
PharmaceuticalsOpen
₹17.9Prev. Close
₹17.1Turnover(Lac.)
₹0.05Day's High
₹17.95Day's Low
₹17.952 Week's High
₹26.0152 Week's Low
₹9.4Book Value
₹-2.55Face Value
₹10Mkt Cap (₹ Cr.)
10.5P/E
0EPS
0Divi. Yield
013 Jun 2025
12:00 AM
AGM
Announcement Date: 13 Jun, 2025
5 Aug 2025
12:00 AM
Board Meeting
Agenda : Audited Result
11 Dec 2024
12:00 AM
EGM
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 5.85 | 5.85 | 5.85 | 5.85 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -7.34 | -7.22 | -7.42 | -3.2 |
Net Worth | -1.49 | -1.37 | -1.57 | 2.65 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 6.32 | 6.59 | 8.17 | 17.18 |
yoy growth (%) | -3.99 | -19.32 | -52.45 | 1.42 |
Raw materials | -3.03 | -4.87 | -4.61 | -12.75 |
As % of sales | 47.91 | 73.96 | 56.43 | 74.23 |
Employee costs | -1.71 | -1.94 | -1.38 | -1.32 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -1.28 | -3.75 | 0.01 | 0.01 |
Depreciation | -1.02 | -0.42 | -0.72 | -0.95 |
Tax paid | 0 | -0.25 | -0.01 | 0 |
Working capital | -0.42 | -4.52 | 1.6 | -0.11 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.99 | -19.32 | -52.45 | 1.42 |
Op profit growth | -93.07 | -485.05 | -29.03 | 183.11 |
EBIT growth | -66.46 | -1,163.58 | 4.51 | -25.64 |
Net profit growth | -65.9 | -2,08,871.63 | -79.24 | -15.55 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,563.35 | 75.31 | 3,75,100.03 | 753.53 | 1.02 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,091.05 | 69.22 | 1,61,698.24 | 557 | 0.49 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,587.6 | 24.82 | 1,28,239.04 | 1,303.13 | 1.01 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,581.55 | 60.97 | 1,21,210.48 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,280.3 | 15.5 | 1,06,852.04 | 2,961.2 | 0.62 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Dhawal Akhilesh Deopura
Managing Director
SARANG PATHAK
Non Executive Director
Hemant Amrish Parikh
Independent Director
Shivani Pathak
Independent Director
Krish Patel
Independent Director
Him Vyas
Executive Director
Vrushank Balkrushna Patel
Executive Director
Nilay Jitendrabhai Vaghasiya
Independent Director
Him Vyas
A-514 Steller Opp Arista Bldg,
Sindhu bhavan Road Bodakdev,
Gujarat - 380054
Tel: 91-02764-286549/286559
Website: http://www.kamronlabs.com
Email: info@kamronlabs.com
5th Floor 506 to 508,
ABC-1 Off C.G Road, Ellisbridge,
Ahmedabad-380006
Tel: 91-79-26465179
Website: www.linkintime.co.in
Email: mt.helpdesk@linkintime.co.in
Summary
Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari. The Company name was changed from Kamron Laboratories Limited to...
Read More
Reports by Adline Chem Lab Ltd
What is the Adline Chem Lab Ltd share price today?
What is the Market Cap of Adline Chem Lab Ltd?
What is the PE and PB ratio of Adline Chem Lab Ltd?
What is the 52 Week High and Low of Adline Chem Lab Ltd?
What is the CAGR of Adline Chem Lab Ltd?
What is the shareholding pattern of Adline Chem Lab Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.